Showing 1–7 of 7 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Ford N, Maher D, Rangaka MX, Baddeley A, Singh S, et al.
Purpose of review Guidelines developed by the WHO aim to provide recommendations to support best practice in health delivery, with a focus on low-income and middle-income countries. As part of the guideline development process, critical knowledge gaps are identified and one of th…
Sashi N Nair, Indira Brar, Gireeshkumar K.P.
…cribed in HIV infected patients. Developed countries, where guidelines on the treatment of PJP have been created have dramatically lower rates of latent and active TB than developing countries. PJP may obscure the diagnosis or delay the treatment of TB. Furthermore, treatment of …
Nair S, Brar I, K.P. G
…cribed in HIV infected patients. Developed countries, where guidelines on the treatment of PJP have been created have dramatically lower rates of latent and active TB than developing countries. PJP may obscure the diagnosis or delay the treatment of TB. Furthermore, treatment of …
M Ameri, L Suarez, Layla Abdul Jabbar, M Koppikar
…lly, recently, concept of roles of nutrition in immunology, latent infections, a short presentation of TB. Further discussing current guidelines, covering topics such as BCG, treatments, role of fluoroquinolones and MDR. With an examination of the social aspect by reviewing the a…
Lewis JH, Korkmaz SY, Rizk CA, Copeland MJ
Introduction Many of the first line medications for the treatment of active and latent M. tuberculosis are hepatoxic and cause a spectrum of anti-tuberculosis drug induced liver injury (ATLI), including acute liver failure (ALF). Despite advances in recognition of and prevention …
J P Le, N Gupta, O Ahmed, P Zafar, R Gul, et al.
…, diabetes, lymphopenia, or immunosuppression. ATS/IDSA/CDC guidelines emphasize that IGRAs and TSTs are not diagnostic for active TB—they do not distinguish latent infection from disease and should not exclude TB when suspicion remains high. The combination of epidemiologic risk…
Chen YH, de Carvalho HM, Kalyoncu U, Llamado LJQ, Solano G, et al.
…re for treating a number of inflammatory diseases. However, treatment with TNF-α inhibitors carries an inherent risk of compromising the immune system, resulting in an increased susceptibility to infections and malignancies. This increased risk of infection is of particular conce…